Sharon B Meropol1, Zhen Chen, Joshua P Metlay. 1. Center for Clinical Epidemiology and Biostatistics, Penn Center for Education and Research on Therapeutics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. meropols@mail.med.upenn.edu
Abstract
BACKGROUND: Recent public health efforts, including in the UK and US, have targeted decreasing unnecessary antibiotic use. In the US, prescribing for acute non-specific respiratory infections (ARIs) has decreased, but broad-spectrum antibacterial prescribing has soared. AIM: To assess recent trends in antibacterial prescribing for ARIs in the UK. DESIGN OF STUDY: Retrospective cohort. SETTING: The Health Improvement Network database. METHOD: Outpatient ARI visits from 1 January 1990 to 31 December 2004 were selected. Outcomes were antibacterial and broad-spectrum antibacterial prescriptions per thousand person-years, and the probability of receiving an antibacterial and broad-spectrum prescription conditional on an ARI visit. RESULTS: From 1990 to 2004, antibacterial prescribing rates for ARIs decreased from 55.0 to 30.3 prescriptions/1000 person-years for adults and from 124.8 to 46.3 prescriptions/1000 person-years for children (P=0.001). The probability of receiving an antibacterial prescription after an ARI visit decreased from 70.8% to 59.5% for adults and from 46.1% to 30.8% for children (P=0.003 and 0.007, respectively). Antibacterial prescribing declined faster for younger than for older adults. Broad-spectrum antibacterial prescribing rates decreased from 3.8 to 2.9 prescriptions/1000 person-years for adults and from 5.2 to 2.2 prescriptions/1000 person years for children (P=0.005 and 0.003, respectively). The probability of broad-spectrum prescribing did not demonstrate a significant linear trend for adults (P=0.16), and decreased for children (P=0.01). CONCLUSION: UK antibacterial prescribing for ARIs has declined, similar to US trends, but there was no concomitant increase in low broad-spectrum prescribing. The success of UK strategies for limiting antimicrobial use has implications for programmes in other countries.
BACKGROUND: Recent public health efforts, including in the UK and US, have targeted decreasing unnecessary antibiotic use. In the US, prescribing for acute non-specific respiratory infections (ARIs) has decreased, but broad-spectrum antibacterial prescribing has soared. AIM: To assess recent trends in antibacterial prescribing for ARIs in the UK. DESIGN OF STUDY: Retrospective cohort. SETTING: The Health Improvement Network database. METHOD:Outpatient ARI visits from 1 January 1990 to 31 December 2004 were selected. Outcomes were antibacterial and broad-spectrum antibacterial prescriptions per thousand person-years, and the probability of receiving an antibacterial and broad-spectrum prescription conditional on an ARI visit. RESULTS: From 1990 to 2004, antibacterial prescribing rates for ARIs decreased from 55.0 to 30.3 prescriptions/1000 person-years for adults and from 124.8 to 46.3 prescriptions/1000 person-years for children (P=0.001). The probability of receiving an antibacterial prescription after an ARI visit decreased from 70.8% to 59.5% for adults and from 46.1% to 30.8% for children (P=0.003 and 0.007, respectively). Antibacterial prescribing declined faster for younger than for older adults. Broad-spectrum antibacterial prescribing rates decreased from 3.8 to 2.9 prescriptions/1000 person-years for adults and from 5.2 to 2.2 prescriptions/1000 person years for children (P=0.005 and 0.003, respectively). The probability of broad-spectrum prescribing did not demonstrate a significant linear trend for adults (P=0.16), and decreased for children (P=0.01). CONCLUSION: UK antibacterial prescribing for ARIs has declined, similar to US trends, but there was no concomitant increase in low broad-spectrum prescribing. The success of UK strategies for limiting antimicrobial use has implications for programmes in other countries.
Authors: Eugene V Millar; Katherine L O'Brien; James P Watt; Melinda A Bronsdon; Jean Dallas; Cynthia G Whitney; Raymond Reid; Mathuram Santosham Journal: Clin Infect Dis Date: 2006-05-18 Impact factor: 9.079
Authors: S Smith; G E Smith; H Heatlie; J N R Bashford; D M Ashcroft; N Q Verlander; G J Duckworth; B Mason; B Smyth; S Maxwell Journal: Public Health Date: 2006-07-07 Impact factor: 2.427
Authors: Christianne L Roumie; Natasha B Halasa; Carlos G Grijalva; Kathryn M Edwards; Yuwei Zhu; Robert S Dittus; Marie R Griffin Journal: J Gen Intern Med Date: 2005-08 Impact factor: 5.128
Authors: Moe H Kyaw; Ruth Lynfield; William Schaffner; Allen S Craig; James Hadler; Arthur Reingold; Ann R Thomas; Lee H Harrison; Nancy M Bennett; Monica M Farley; Richard R Facklam; James H Jorgensen; John Besser; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney Journal: N Engl J Med Date: 2006-04-06 Impact factor: 91.245
Authors: Christopher C Butler; Kathryn O'Brien; Timothy Pickles; Kerenza Hood; Mandy Wootton; Robin Howe; Cherry-Ann Waldron; Emma Thomas-Jones; William Hollingworth; Paul Little; Judith Van Der Voort; Jan Dudley; Kate Rumsby; Harriet Downing; Kim Harman; Alastair D Hay Journal: Br J Gen Pract Date: 2015-04 Impact factor: 5.386
Authors: V Papaevangelou; A Rousounides; A Hadjipanagis; A Katsioulis; M Theodoridou; C Hadjichristodoulou Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: Harriet Downing; Emma Thomas-Jones; Micaela Gal; Cherry-Ann Waldron; Jonathan Sterne; William Hollingworth; Kerenza Hood; Brendan Delaney; Paul Little; Robin Howe; Mandy Wootton; Alastair Macgowan; Christopher C Butler; Alastair D Hay Journal: BMC Infect Dis Date: 2012-07-19 Impact factor: 3.090